These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15554329)

  • 1. [Role of lipopolysaccharide in the action of complement on gram negative bacteria].
    Lobanov VV
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (5):114-8. PubMed ID: 15554329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vibrio cholerae O139 capsular polysaccharide confers complement resistance in the absence or presence of antibody yet presents a productive target for cell lysis: implications for detection of bactericidal antibodies.
    Attridge SR; Holmgren J
    Microb Pathog; 2009 Dec; 47(6):314-20. PubMed ID: 19818394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of a Glycoconjugate from Hydrazine-Detoxified Lipopolysaccharide of Vibrio cholerae O139.
    Fleischhackerová-Slimáková A; Korcová J; Bystrický S
    Scand J Immunol; 2017 Dec; 86(6):444-451. PubMed ID: 29063635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of bacterial resistance to complement-mediated killing and on the mechanism of action of bactericidal antibody.
    Joiner KA
    Curr Top Microbiol Immunol; 1985; 121():99-133. PubMed ID: 3910367
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of polysaccharide antigens of Vibrio cholerae O139 of different origin by monoclonal antibodies].
    Alekseeva LP; Mazrukho BL; Chemisova OS; Sal'nikova OI; Markina OV; Lobanov VV
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (4):25-9. PubMed ID: 12449693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential immunogenicity of Vibrio cholerae O139 variants expressing different combinations of naturally occurring and atypical forms of the serogroup polysaccharide.
    Attridge SR; Wallerström G; Li BL; Morona R; Holmgren J
    Vaccine; 2009 Feb; 27(7):1055-61. PubMed ID: 19100303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in Bangladesh.
    Qadri F; Svennerholm AM; Shamsuzzaman S; Bhuiyan TR; Harris JB; Ghosh AN; Nair GB; Weintraub A; Faruque SM; Ryan ET; Sack DA; Calderwood SB
    Infect Immun; 2005 Oct; 73(10):6577-83. PubMed ID: 16177333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement and bacteria: chemistry and biology in host defense.
    Joiner KA; Brown EJ; Frank MM
    Annu Rev Immunol; 1984; 2():461-91. PubMed ID: 6399850
    [No Abstract]   [Full Text] [Related]  

  • 9. The mechanism by which microorganisms avoid complement attack.
    Frank MM
    Curr Opin Immunol; 1992 Feb; 4(1):14-9. PubMed ID: 1596364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TcpF is a soluble colonization factor and protective antigen secreted by El Tor and classical O1 and O139 Vibrio cholerae serogroups.
    Kirn TJ; Taylor RK
    Infect Immun; 2005 Aug; 73(8):4461-70. PubMed ID: 16040956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dry-reagent gold nanoparticle-based lateral flow biosensor for the simultaneous detection of Vibrio cholerae serogroups O1 and O139.
    Yu CY; Ang GY; Chua AL; Tan EH; Lee SY; Falero-Diaz G; Otero O; Rodríguez I; Reyes F; Acosta A; Sarmiento ME; Ghosh S; Ramamurthy T; Yean Yean C; Lalitha P; Ravichandran M
    J Microbiol Methods; 2011 Sep; 86(3):277-82. PubMed ID: 21571011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The function of antibody and complement in the lysis of bacteria.
    Frank MM; Joiner K; Hammer C
    Rev Infect Dis; 1987; 9 Suppl 5():S537-45. PubMed ID: 3317749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human monoclonal antibodies to glycolipid A that exhibit complement species-specific effector functions.
    Winkelhake JL; Gauny SS; Senyk G; Piazza D; Stevens P
    J Infect Dis; 1992 Jan; 165(1):26-33. PubMed ID: 1727895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation by lipopolysaccharides purified from gram-negative bacteria isolated from infected root canals.
    Horiba N; Maekawa Y; Yamauchi Y; Ito M; Matsumoto T; Nakamura H
    Oral Surg Oral Med Oral Pathol; 1992 Nov; 74(5):648-51. PubMed ID: 1437068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides mimicking Vibrio cholerae O139 capsular polysaccharide elicit protective antibody response.
    Falklind-Jerkérus S; Felici F; Cavalieri C; Lo Passo C; Garufi G; Pernice I; Islam MM; Qadri F; Weintraub A
    Microbes Infect; 2005 Dec; 7(15):1453-60. PubMed ID: 16046165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation.
    de Haas CJ; van Leeuwen EM; van Bommel T; Verhoef J; van Kessel KP; van Strijp JA
    Infect Immun; 2000 Apr; 68(4):1753-9. PubMed ID: 10722560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.
    Saha D; LaRocque RC; Khan AI; Harris JB; Begum YA; Akramuzzaman SM; Faruque AS; Ryan ET; Qadri F; Calderwood SB
    J Infect Dis; 2004 Jun; 189(12):2318-22. PubMed ID: 15181581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-independent killing of gram-negative bacteria via the classical pathway of complement.
    Loos M; Clas F
    Immunol Lett; 1987 Feb; 14(3):203-8. PubMed ID: 3032781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of bacterial infections: some determinants of virulence in Gram negative bacteria.
    Woolcock JB
    Aust Vet J; 1985 Jun; 62(6):177-81. PubMed ID: 3904701
    [No Abstract]   [Full Text] [Related]  

  • 20. Gram-negative bacteria killed by complement are associated with more severe biliary infections and produce more tumor necrosis factor-alpha in sera.
    Stewart L; Oesterle AL; Griffiss JM; Jarvis GA; Aagaard B; Way LW
    Surgery; 2002 Aug; 132(2):408-14. PubMed ID: 12219042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.